Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis

被引:124
作者
Nagasue, N [1 ]
Ono, T [1 ]
Yamanoi, A [1 ]
Kohno, H [1 ]
El-Assal, ON [1 ]
Taniura, H [1 ]
Uchida, M [1 ]
机构
[1] Shimane Med Univ, Dept Surg 2, Izumo, Shimane 6938501, Japan
关键词
D O I
10.1046/j.1365-2168.2001.01732.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Detailed follow-up of patients with chronic hepatitis has resulted in increased diagnosis of hepatocellular carcinoma (HCC) in patients without cirrhosis. Despite numerous studies on hepatic resection, the prognostic factors for intrahepatic recurrence and survival are not well known for patients with HCC without cirrhosis. Methods: Among 349 patients with HCC treated in the past 13 years, cirrhosis was absent in 126 patients (36 per cent). Curative hepatic resection was carried out in 100 (79 per cent) of these patients. Risk factors for intrahepatic recurrence and prognostic factors for survival were evaluated by univariate and multivariate analyses. Results: Postoperative morbidity and mortality rates were 22 and 3 per cent respectively. The 5- and 10-year disease-free and overall survival rates were 31 and 50 per cent, and 22 and 47 per cent respectively. Blood loss, surgical resection margin, intrahepatic metastasis, portal vein invasion and extent of hepatic resection were independently associated with overall survival. However, the only risk factors for intrahepatic recurrence were portal vein invasion and hepatitis C virus (HCV) infection. The former was related to early recurrence while the latter was related to later recurrence. The 5-year disease-free survival rate was 58 per cent in patients with hepatitis B virus infection while it was 6 per cent in patients with HCV infection (P < 0.001). Conclusion: In the treatment of HCC without cirrhosis, major hepatectomy is advocated to prevent early recurrence. Liver transplantation may be required for patients with HCV infection.
引用
收藏
页码:515 / 522
页数:8
相关论文
共 32 条
  • [1] [Anonymous], 1983, MANUAL STAGING CANC
  • [2] MORPHOLOGY OF CIRRHOSIS
    ANTHONY, PP
    ISHAK, KG
    NAYAK, NC
    POULSEN, HE
    SCHEUER, PJ
    SOBIN, LH
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1978, 31 (05) : 395 - 414
  • [3] Liver transplantation for hepatocellular carcinoma
    Bismuth, H
    Majno, PE
    Adam, R
    [J]. SEMINARS IN LIVER DISEASE, 1999, 19 (03) : 311 - 322
  • [4] BITHMUTH H, 1995, WORLD J SURG, V10, P35
  • [5] COLOMBO M, 1989, LANCET, V2, P1006
  • [6] Couinaud C., 1957, FOIE ETUDES ANATOMIQ
  • [7] HCV-ASSOCIATED LIVER-CANCER WITHOUT CIRRHOSIS
    DEMITRI, MS
    POUSSIN, K
    BACCARINI, P
    PONTISSO, P
    DERRICO, A
    SIMON, N
    GRIGIONI, W
    ALBERTI, A
    BEAUGRAND, M
    PISI, E
    BRECHOT, C
    PATERLINI, P
    [J]. LANCET, 1995, 345 (8947): : 413 - 415
  • [8] DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629
  • [9] HEPATITIS-C AND HEPATOCELLULAR-CARCINOMA
    DIBISCEGLIE, AM
    [J]. SEMINARS IN LIVER DISEASE, 1995, 15 (01) : 64 - 69
  • [10] HCV-associated hepatocellular carcinoma without cirrhosis
    ElRefaie, A
    Savage, K
    Bhattacharya, S
    Khakoo, S
    Harrison, TJ
    ElBatanony, M
    Soliman, ES
    Nasr, S
    Mokhtar, N
    Amer, K
    Scheuer, PJ
    Dhillon, AP
    [J]. JOURNAL OF HEPATOLOGY, 1996, 24 (03) : 277 - 285